Login / Signup
Mohsen Motavaselian
ORCID
Publication Activity (10 Years)
Years Active: 2024-2024
Publications (10 Years): 3
Top Topics
Autism Spectrum Disorder
Phase Iii
Clinical Trial
Open Label
Top Venues
Expert opinion on emerging drugs
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Ahmad Shamabadi
,
Hanie Karimi
,
Razman Arabzadeh Bahri
,
Mohsen Motavaselian
,
Shahin Akhondzadeh
Emerging drugs for the treatment of irritability associated with autism spectrum disorder.
Expert opinion on emerging drugs
29 (1) (2024)
Ahmad Shamabadi
,
Hanie Karimi
,
Razman Arabzadeh Bahri
,
Mohsen Motavaselian
,
Shahin Akhondzadeh
Emerging drugs for the treatment of irritability associated with autism spectrum disorder.
Expert opinion on emerging drugs
29 (1) (2024)
Ahmad Shamabadi
,
Hanie Karimi
,
Razman Arabzadeh Bahri
,
Mohsen Motavaselian
,
Shahin Akhondzadeh
Emerging drugs for the treatment of irritability associated with autism spectrum disorder.
Expert opinion on emerging drugs
(2024)